Chief Physician, Associate Professor, Master's Supervisor. Over the years, primarily engaged in the diagnosis and treatment of oncology, especially malignant lymphoma, hematopoietic stem cell transplantation, tumor biological immunotherapy, and hematological diseases, accumulating extensive clinical experience. Mainly dedicated to the diagnosis and treatment of malignant lymphoma, with a focus on central nervous system lymphoma, T-cell lymphoma diagnosis and treatment, and the relationship between malignant lymphoma and hepatitis B. Has published over 30 papers in various national core journals, including 4 SCI papers as the first author. Co-translated two monographs, namely "Clinical Oncology" (American) and "Immunotherapy for Malignant Lymphoma," and co-edited the second edition of "Chinese Obstetrics and Gynecology," "Drug Therapy for Gastrointestinal Diseases," and "Lymphoma Diagnosis and Treatment Standards" from Peking University Cancer Hospital. As the principal investigator, undertook one Capital Medical Development Scientific Research Fund project and three Peking University Cancer Hospital Scientific Research Fund projects. As a key member, participated in research under the National "211" Project, the National Natural Science Foundation of China, and Beijing municipal projects. Involved in multiple domestic and international multicenter clinical studies. Member of the Chinese Society of Clinical Oncology, and member of the Clinical Oncology Professional Committee of the Chinese Women's Medical Association. Awarded the Third Prize of Beijing Science and Technology Progress.